Prelude Capital Management’s Teladoc Health TDOC Stock Holding History

Prelude Capital Management’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-4,300	Closed	-$310K	–	2053
2022 Q1	$310K	Sell	4,300 -5,500	-56%	-$396K	0.01%	1061
2021 Q4	$900K	Buy	9,800 +3,700	+61%	+$442K	0.02%	667
2021 Q3	$774K	Buy	+6,100	New	+$888K	0.02%	678
2020 Q3	–	Sell	-100	Closed	-$19K	–	2331
2020 Q2	$19K	Buy	+100	New	+$17.5K	﹤0.01%	1401
2019 Q1	–	Sell	-100	Closed	-$5K	–	2166
2018 Q4	$5K	Buy	+100	New	+$6.12K	﹤0.01%	1622
2018 Q1	–	Sell	-25,200	Closed	-$878K	–	1716
2017 Q4	$878K	Buy	+25,200	New	+$837K	0.07%	283

Other funds holding TDOC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Prelude Capital Management's TDOC Position: Q1 2026 in Review

Prelude Capital Management increased its Teladoc Health (TDOC) stake by 4.1% in Q1 2026, buying an estimated $13.9K and bringing the position to 63,085 shares worth $344K. The position accounts for 0.03% of the portfolio, ranked #653.

Prelude Capital Management first reported a position in TDOC in Q1 2020 and has held it in 14 quarters since. The position peaked at $1.31M in Q3 2025. 323 funds tracked by Wall St. Rank hold TDOC as of Q1 2026.

Prelude Capital Management held 63,085 shares of Teladoc Health worth $344K as of Q1 2026.
Prelude Capital Management bought 2,485 Teladoc Health shares in Q1 2026, an estimated $13.9K.
Teladoc Health made up 0.03% of Prelude Capital Management's portfolio in Q1 2026, its #653 holding.
Prelude Capital Management first reported a position in Teladoc Health in Q1 2020 and has held it in 14 quarters since.
Prelude Capital Management's Teladoc Health position peaked at $1.31M in Q3 2025.
323 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2026.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.